![]() ![]() However, those companies reached a settlement with BMS and Pfizer that prevents either from entering the market until at least 2026. The Food & Drug Administration (FDA) has granted approval of the generic Eliquis (apixaban) applications to both Micro Labs Limited and Mylan Pharmaceuticals Inc. The decision meant that any and all generic-producing rivals are blocked from producing generics for at least 6 years. On August 6, 2020, the joint manufacturers of Eliquis – Bristol Myers Squibb (BMS) and Pfizer – celebrated a victory in federal court which upheld their patent claims for the medication.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |